Conflict and Health
Volume 11, Issue 1, 2017

Low levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee camp (Article) (Open Access)

Mendelsohn J.B.* , Spiegel P. , Grant A. , Doraiswamy S. , Schilperoord M. , Larke N. , Burton J.W. , Okonji J.A. , Zeh C. , Muhindo B. , Mohammed I.M. , Mukui I.N. , Patterson N. , Sondorp E. , Ross D.A.
  • a College of Health Professions, Pace University, New York, NY, United States, MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • b Public Health and HIV Unit, United Nations High Commissioner for Refugees, Geneva, Switzerland, Center for Refugee and Disaster Response, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States
  • c Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • d East Africa Regional Office, United Nations High Commissioner for Refugees, Nairobi, Kenya
  • e Public Health and HIV Unit, United Nations High Commissioner for Refugees, Geneva, Switzerland
  • f MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • g Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • h Center for Global Health Research and HIV-Research Laboratory, Kenya Medical Research Institute, Kisumu, Kenya, Clinical and Laboratory Standards Institute, Centers for Disease Control and Prevention Program-Kenya, Kisumu, Kenya
  • i Center for Global Health Research and HIV-Research Laboratory, Kenya Medical Research Institute, Kisumu, Kenya
  • j Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • k National AIDS/STD Control Program, Nairobi, Kenya
  • l National AIDS/STD Control Program, Nairobi, Kenya
  • m Public Health and HIV Unit, United Nations High Commissioner for Refugees, Geneva, Switzerland
  • n Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • o MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom, World Health Organization, Geneva, Switzerland

Abstract

Background: Refugees and host nationals who accessed antiretroviral therapy (ART) in a remote refugee camp in Kakuma, Kenya (2011-2013) were compared on outcome measures that included viral suppression and adherence to ART. Methods: This study used a repeated cross-sectional design (Round One and Round Two). All adults (≥18 years) receiving care from the refugee camp clinic and taking antiretroviral therapy (ART) for ≥30 days were invited to participate. Adherence was measured by self-report and monthly pharmacy refills. Whole blood was measured on dried blood spots. HIV-1 RNA was quantified and treatment failures were submitted for drug resistance testing. A remedial intervention was implemented in response to baseline testing. The primary outcome was viral load <5000 copies/mL. The two study rounds took place in 2011-2013. Results: Among eligible adults, 86% (73/85) of refugees and 84% (86/102) of Kenyan host nationals participated in the Round One survey; 60% (44/73) and 58% (50/86) of Round One participants were recruited for Round Two follow-up viral load testing. In Round One, refugees were older than host nationals (median age 36 years, interquartile range, IQR 31, 41 vs 32 years, IQR 27, 38); the groups had similar time on ART (median 147 weeks, IQR 38, 64 vs 139 weeks, IQR 39, 225). There was weak evidence for a difference between proportions of refugees and host nationals who were virologically suppressed (<5000 copies/mL) after 25 weeks on ART (58% vs 43%, p = 0.10) and no difference in the proportions suppressed at Round Two (74% vs 70%, p = 0.66). Mean adherence within each group in Round One was similar. Refugee status was not associated with viral suppression in multivariable analysis (adjusted odds ratio: 1.69, 95% CI 0.79, 3.57; p = 0.17). Among those not suppressed at either timepoint, 69% (9/13) exhibited resistance mutations. Conclusions: Virologic outcomes among refugees and host nationals were similar but unacceptably low. Slight improvements were observed after a remedial intervention. Virologic monitoring was important for identifying an underperforming ART program in a remote facility that serves refugees alongside host nationals. This work highlights the importance of careful laboratory monitoring of vulnerable populations accessing ART in remote settings. © 2017 The Author(s).

Author Keywords

Migration Antiretroviral therapy HIV adherence Kenya Refugee

Index Keywords

[No Keywords available]

Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020011104&doi=10.1186%2fs13031-017-0111-3&partnerID=40&md5=d3935d41fa59e4e89b35b5f986b2fda9

DOI: 10.1186/s13031-017-0111-3
ISSN: 17521505
Cited by: 2
Original Language: English